Mixed
GLP-1 receptor agonists for obesity treatment cause significant loss of lean body mass (including muscle) and bone density, with muscle loss accounting for approximately 20% of total weight reduction in the absence of structured resistance training.
If you are taking GLP-1s for weight loss, you must incorporate resistance training (weight lifting or bodyweight exercises) at least 2-3 times per week. Without this, roughly 20% of the weight you lose will be muscle, not just fat. Ensure you are eating enough protein to support muscle retention during the caloric deficit.
In the STEP 1 trial, of the average 13.6-kg–weight reduction, 8.3 kg (62%) was fat mass and 5.3 kg (38%) was lean body mass (including muscle and other non-fat tissues)... this corresponds to ~20% of total weight reduction being muscle loss... Modeling data suggest that loss of muscle mass varies by sex, representing 10%–15% of total weight reduction in females and 20%–25% of total weight reduction in males, in the absence of structured strength training [64].
Why this rating
Based on landmark industry-sponsored randomized controlled trials (STEP 1, SURMOUNT 1) with large sample sizes and rigorous methodology.
Source
Nutritional priorities to support <scp>GLP</scp>‐1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society
Dariush Mozaffarian et al. · Obesity · 2025
DOI 10.1002/oby.24336
More from this paper
- Discontinuation of GLP-1 therapy leads to significant weight regain (up to two-thirds of lost weight within 1 year), highlighting the necessity of long-term lifestyle interventions and potentially long-term medication use.Strong
- Rapid and substantial weight reduction via GLP-1 therapy increases the risk of nutrient deficiencies and bone density loss, particularly when caloric intake drops below 1200 kcal/day for females or 1800 kcal/day for males without nutritional counseling.Good
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →